KUMAR NEIL (See Remarks) sold 1.8% of their position (80K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $5.41M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−2.20K
Price / share
$65.72
Trade value
$144.58K
% of position
Common Stock
Shares
−1.43K
Price / share
$66.72
Trade value
$95.35K
% of position
Common Stock
Shares
−15.92K
Price / share
$67.74
Trade value
$1.08M
% of position
Common Stock
Shares
−450.00
Price / share
$68.27
Trade value
$30.72K
% of position
Common Stock
Shares
−2.20K
Price / share
$65.72
Trade value
$144.58K
% of position
Common Stock
Shares
−1.43K
Price / share
$66.72
Trade value
$95.35K
% of position
Common Stock
Shares
−15.92K
Price / share
$67.74
Trade value
$1.08M
% of position
Common Stock
Shares
−450.00
Price / share
$68.27
Trade value
$30.72K
% of position
Common Stock
Shares
−7.15K
Price / share
$67.20
Trade value
$480.27K
% of position
Common Stock
Shares
−8.44K
Price / share
$67.88
Trade value
$572.74K
% of position
Common Stock
Shares
−4.42K
Price / share
$68.96
Trade value
$304.52K
% of position
Common Stock
Shares
−7.15K
Price / share
$67.20
Trade value
$480.34K
% of position
Common Stock
Shares
−8.44K
Price / share
$67.88
Trade value
$572.74K
% of position
Common Stock
Shares
−4.42K
Price / share
$68.96
Trade value
$304.46K
% of position
Net shares
−80K
Net value
-$5.41M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/4/2026 | S · Sale | −2.20K | $65.72 | $144.58K | 0.4% | 555.69K | 553.49K |
| Common Stock Indirect | 6/4/2026 | S · Sale | −1.43K | $66.72 | $95.35K | 0.3% | 553.49K | 552.06K |
| Common Stock Indirect | 6/4/2026 | S · Sale | −15.92K | $67.74 | $1.08M | 2.9% | 552.06K | 536.14K |
| Common Stock Indirect | 6/4/2026 | S · Sale | −450.00 | $68.27 | $30.72K | 0.1% | 536.14K | 535.69K |
| Common Stock Indirect | 6/4/2026 | S · Sale | −2.20K | $65.72 | $144.58K | 0.1% | 4.36M | 4.36M |
| Common Stock Indirect | 6/4/2026 | S · Sale | −1.43K | $66.72 | $95.35K | 0.0% | 4.36M | 4.35M |
| Common Stock Indirect | 6/4/2026 | S · Sale | −15.92K | $67.74 | $1.08M | 0.4% | 4.35M | 4.34M |
| Common Stock Indirect | 6/4/2026 | S · Sale | −450.00 | $68.27 | $30.72K | 0.0% | 4.34M | 4.34M |
| Common Stock Indirect | 6/5/2026 | S · Sale | −7.15K | $67.20 | $480.27K | 1.3% | 535.69K | 528.54K |
| Common Stock Indirect | 6/5/2026 | S · Sale | −8.44K | $67.88 | $572.74K | 1.6% | 528.54K | 520.10K |
| Common Stock Indirect | 6/5/2026 | S · Sale | −4.42K | $68.96 | $304.52K | 0.8% | 520.10K | 515.69K |
| Common Stock Indirect | 6/5/2026 | S · Sale | −7.15K | $67.20 | $480.34K | 0.2% | 4.34M | 4.33M |
| Common Stock Indirect | 6/5/2026 | S · Sale | −8.44K | $67.88 | $572.74K | 0.2% | 4.33M | 4.32M |
| Common Stock Indirect | 6/5/2026 | S · Sale | −4.42K | $68.96 | $304.46K | 0.1% | 4.32M | 4.32M |
| Total | −80K | -$5.41M | ||||||
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 243.33K | Direct |
| Total | 243.33K | 243.33K direct |